The IB kinases IKK␣ and IKK␤ are critical in activating the NF-B pathway. Although these proteins have a similar structure that includes kinase, leucine zipper, and helix-loop-helix domains, they exhibit marked differences in their kinase activity and functional properties. For example, IKK␤ has a 10 -20-fold higher level of kinase activity for IB␣ than does IKK␣. Furthermore, disruption of the murine IKK␤ gene, but not the IKK␣ gene, results in severe defects in activating the NF-B pathway. Mice lacking IKK␤ succumb to severe hepatic apoptosis because of failure to activate the NF-B pathway, whereas mice deficient in IKK␣ exhibit skin and skeletal abnormalities and an embryonic lethal phenotype. To better characterize differences in the functional properties of these kinases, hybrid IKK proteins were constructed by domain swapping, and their kinase activity was assayed. These studies demonstrated that differences in the IKK␣ and IKK␤ helix-loop-helix domains are primarily responsible for differences in their kinase activity. In contrast, their kinase and leucine zipper domains exhibited relatively conserved function. These studies further define the properties of IKK␣ and IKK␤, which are involved in their unique regulatory roles.
The IB kinases IKK␣ and IKK␤ are critical in activating the NF-B pathway. Although these proteins have a similar structure that includes kinase, leucine zipper, and helix-loop-helix domains, they exhibit marked differences in their kinase activity and functional properties. For example, IKK␤ has a 10 -20-fold higher level of kinase activity for IB␣ than does IKK␣. Furthermore, disruption of the murine IKK␤ gene, but not the IKK␣ gene, results in severe defects in activating the NF-B pathway. Mice lacking IKK␤ succumb to severe hepatic apoptosis because of failure to activate the NF-B pathway, whereas mice deficient in IKK␣ exhibit skin and skeletal abnormalities and an embryonic lethal phenotype. To better characterize differences in the functional properties of these kinases, hybrid IKK proteins were constructed by domain swapping, and their kinase activity was assayed. These studies demonstrated that differences in the IKK␣ and IKK␤ helix-loop-helix domains are primarily responsible for differences in their kinase activity. In contrast, their kinase and leucine zipper domains exhibited relatively conserved function. These studies further define the properties of IKK␣ and IKK␤, which are involved in their unique regulatory roles.
The NF-B pathway is important for regulating the expression of cellular genes that are involved in the control of the immune and inflammatory response (1, 2) . In addition, NF-B is also involved in preventing cellular apoptosis (1, 2) . In most cells, NF-B is sequestered in the cytoplasm bound to a family of inhibitory proteins known as IB (1) (2) (3) . The NF-B pathway is activated by a variety of agents including cytokines such as tumor necrosis factor ␣ and interleukin-1, phorbol esters, lipopolysaccharides, and bacterial and viral infection (4 -10) . Activation of the NF-B pathway is mediated by increases in the activity of two kinases that phosphorylate IB designated IKK␣ and IKK␤ (11) (12) (13) (14) (15) .
IKK␣ and IKK␤ phosphorylate amino-terminal serine residues in the IB family of proteins that includes IB␣, IB␤, and IB⑀ (11) (12) (13) (14) (15) . Phosphorylation of IB leads to its ubiquitination and subsequent degradation by the proteasome resulting in the nuclear translocation of NF-B (16 -21) . IKK␣ and IKK␤ are components of a 700-kDa multi-protein complex (16, 17, 22, 23) that contains other factors including NEMO (23) (24) (25) and IKAP (26) . IKK␣ and IKK␤ are primarily associated as heterodimers in this 700-kDa IKK complex (11) (12) (13) (14) (15) , whereas IKK␤ homodimers are detected in a lower molecular weight complex (12, 27) . Although both IKK␣ and IKK␤ phosphorylate the amino terminus of IB, the activity of IKK␤ is approximately 20-fold higher than that of IKK␣ (12, 15, 28 -31) .
IKK␣ and IKK␤ have 52% amino acid identity with a similar structural organization, which includes kinase, leucine zipper, and helix-loop-helix domains (11) (12) (13) (14) (15) . The kinase domain of these proteins contains a MAP 1 kinase activation loop with closely spaced serine residues at positions 176 and 180 in IKK␣ and positions 177 and 181 in IKK␤ (11) (12) (13) (14) (15) . Phosphorylation of these serine residues by upstream kinases, including NIK and MEKK1, activates IKK kinase activity (22, 28, 29, (32) (33) (34) . Mutation of these serine residues to alanine markedly reduces IKK kinase activity, whereas substitution of these serine residues with glutamic acid to mimic serine phosphorylation stimulates IKK kinase activity (12, 25, 34) . In addition, serine residues located carboxyl-terminal to the HLH domain are also critical in regulating IKK␤ kinase activity (32) . Mutation of these serine residues to alanine leads to prolonged IKK activation, suggesting that phosphorylation of these residues, likely by autophosphorylation, functions to down-regulate IKK␤ activity.
Mutation of either the leucine zipper or the helix-loop-helip domain prevents IKK kinase activity (32, 35) . The leucine zipper motif mediates IKK heterodimerization and homodimerization, whereas the helix-loop-helix domain functions in modulating IKK kinase activity (32, 35) . For example, transfection of an expression vector containing an IKK␤ construct in which the helix-loop-helix domain is deleted exhibits markedly reduced kinase activity as compared with wild-type IKK␤ (32) . However, the kinase activity of this mutated IKK␤ protein can be restored by transfection of an expression vector encoding the HLH domain alone. This result indicates a critical role for the IKK␤ helix-loop-helix domain in regulating IKK activity.
Mice in which either the IKK␣ or IKK␤ genes are disrupted exhibit unique phenotypes (36 -39) . For example, disruption of the IKK␣ gene results in embryonic lethality, which is associated with a variety of abnormalities including epidermal hyperplasia and defective limb formation (36, 37, 39) . Only modest defects in the activation of the NF-B pathway are noted in these IKK␣-deficient mice. In contrast, mice lacking the IKK␤ gene succumb to massive hepatic apoptosis immediately following birth (38) . These defects are due to the fact that these IKK␤-deficient mice are extremely defective in activating in the NF-B pathway. Thus, IKK␤ is more critical than is IKK␣ in activating the NF-B pathway.
In the current study, we characterized functional differences between IKK␣ and IKK␤. Chimeric IKK␣ and IKK␤ kinases were constructed by domain swapping of the kinase, leucine zipper, or helix-loop-helix domains. We find that differences in the helix-loop-helix domains of IKK␣ and IKK␤ are critical in regulating differential IKK kinase activity. These studies address important aspects of IKK function involved in their activation of the NF-B pathway.
MATERIALS AND METHODS
Cell Culture and Transfection Assays-COS cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. Aspirin (Sigma) and sulindac sulfide (Merck) were dissolved in 1 M Tris-HCl, pH 8.0, to make stock solutions. In transfection assays, aspirin and sulindac sulfide were used at a concentrations of 5 mM and 200 M, respectively (31, 40) . Aspirin and sulindac sulfide were added to the cell culture medium at 30 h post-transfection and incubated for 2 h prior to preparation of cellular extracts.
Expression vectors (50 ng to 1 g) encoding the IKK hybrids alone or in the presence of NIK or MEKK1 expression vectors were transfected into approximately 80% confluent COS cells in 60-mm tissue culture plates using Fugene 6 (Roche Molecular Biochemicals). Cells were harvested 32 h after the transfection, and extracts were prepared for immunoprecipitation and assays of kinase activity as described (30, 31, 40) .
Construction of IKK Hybrids-IKK hybrids were constructed using recombinant PCR (41) by swapping IKK␣ and IKK␤ kinase (KD), leucine zipper (LZ), or HLH domains. The constructs generated included IKK(␣K/␤LH), IKK(␤K/␣LH), IKK(␣KL/␤H), and IKK(␤KL/␣H). The vectors pRcBactHA-IKK␣WT and pCMV2-pFLAG-IKK␤WT were used as templates for the PCR (12) . To construct IKK(␣K/␤LH), the oligonucleotide primer set, 5Ј-GAA TTC AAG CTT ATG GAG CGG CCC CCG GG GCT GCG GC-3Ј and 5Ј-GAT GTC ATC CAG GGC CTT AAA ACA TCT TGG CTG CTT-3Ј, was used for PCR with the template pRcBactHA-IKK␣WT to generate the KD of IKK␣. The oligonucleotide primer set, 5Ј-AAG CAG CCA AGA TGT TTT AAG GCC CTG GAT GAC ATC T-3Ј and 5Ј-CTA GTC TAG ATC ATG AGG CCT GCT CCA GGC AGC-3Ј, was used for PCR with pCMV2-pFLAG-IKK␤WT to generate the LZ and HLH domains of IKK␤. These two PCR products were used for template-independent PCR, and the final PCR product was cloned into the HindIII and KpnI restriction sites of pCMV2-pFLAG.
For each of the constructs described below, a similar strategy was used as detailed in the preceding paragraph. IKK(␤K/␣LH) was constructed using the oligonucleotide primers 5Ј-TGG GCC CAA TGG CTG CTT CGT ATT AAG GAT CAC ATT-3Ј and 5Ј-CAT AGG AAG CTT TCA TTC TGT TAA CCA ACT CCA ATC-3Ј with pCMV2-pFLAG-IKK␤WT used as the template to isolate the KD of IKK␤. The other primer set, 5Ј-CAT GGC AAG CTT ATG AGC GGT CAC CTT CCC TGA CA-3Ј and 5Ј-AAT GTG ATC CAT AAT ACG AAG CAG CCA TTG GGC CCA T-3Ј, was used in PCR analysis with the template pRcBactHA-IKK␣WT to generate the LZ and HLH domains of IKK␣. The two PCR products were fused by PCR to generate IKK(␤K/␣LH).
IKK(␣KL/␤H) was prepared using the oligonucleotide primers, 5Ј-GAA TTC AAG CTT ATG GAG CGG CCC CCG GG GCT GCG GC-3Ј and 5Ј-CTC TAG GTCGTC CAG CGT GTC TCC CTG ACG TCT TCC-3Ј, with the template pRcBactHA-IKK␣WT to isolate the KD and LZ domains of IKK␣. The other set of oligonucleotide primers, 5Ј-CTA GTC TAG ATC ATG AGG CCT GCT CCA GGC AGC-3Ј and 5Ј-GGA AGA CGT CAG GGA GAC ACG CTG GAC GAC CTA GAG-3Ј, was used in PCR with the pCMV2-pFLAG-IKK␤WT template to generate the HLH of IKK␤. The two fragments were used in PCR to generate IKK(␣KL/␤H).
To construct IKK(␤KL/␣H), the KD and LZ domains of IKK␤ were prepared by using the oligonucleotide primers, 5Ј-CAT AGG AAG CTT TCA TTC TGT TAA CCA ACT CCA ATC-3Ј and 5Ј-GGC CGG AAG CAG GGG GGA TTG ATG GAA TCT CTG GAA-3Ј in PCR with the template pCMV2-pFLAG-IKK␤WT. The HLH domain of IKK␣ was produced by PCR using the oligonucleotide primer set, 5Ј-CAT GGC AAG CTT ATG AGC GGT CAC CTT CCC TGA CA-3Ј and 5Ј-TTC CAG AGA TTC CAT CAA TCC CCC CTG CTT CCG GCC C-3Ј, with the template pRcBactHA-IKK␣WT. The two fragments were fused by PCR to generate IKK(␤KL/␣H).
IKK␣ and IKK␤ kinase domains containing either constitutively active (SS/EE) or inactive (SS/AA) mutations in the MAP kinase activation loop were fused to the LZ and HLH domains of wild-type IKK␤ and IKK␣ using a similar strategy as described. The mutants constructed were IKK(␣K/␤LH) SS/EE, IKK(␤K/␣LH) SS/EE, IKK(␣K/ ␤LH) SS/AA, and IKK(␤K/␣LH) SS/AA. The mutant IKK(␣K/␤LH) SS/EE was generated using PCR with the oligonucleotide primers 5Ј-GAA TTC AAG CTT ATG GAG CGG CCC CCG GG GCT GCG GC-3Ј and 5Ј-GAT GTC ATC CAG GGC CTT AAA ACA TCT TGG CTG CTT-3Ј and the template IKK␣ SS/EE to generate the KD. This PCR product was used as megaprimer with the oligonucleotide primer 5Ј-GCA GGT ACC TCA TGA GGC CTG CTC CAG GCA G-3Ј and the template pCMV2-pFLAG-IKK(␣K/␤LH) to generate IKK(␣K/␤LH)SS/EE. To construct IKK(␣K/␤LH) SS/AA, PCR was performed with template IKK␣ SS/AA using same oligonucleotide primer set used to generate the KD of IKK␣ SS/EE. PCR was performed with the KD fragment of IKK␣ SS/AA and the oligonucleotide primer 5Ј-GCA GGT ACC TCA TGA GGC CTG CTC CAG GCA G-3Ј with the template pCMV2-pFLAG-IKK(␣K/␤LH) to generate IKK(␣K/␤LH) SS/AA. IKK(␤K/␣LH) SS/EE was constructed using the oligonucleotide primer set, 5Ј-CAT GGC AAG CTT ATG AGC TGG TCA CCT TCC CTG ACA-3Ј and 5Ј-AAT GTG ATC CAT AAT ACG AAG CAG CCA TTG GGC CCA T-3Ј and the template IKK␤ SS/EE to generate the KD. The first PCR product was used as megaprimer with the oligonucleotide 5Ј-CAT AGG AAG CTT TCA TTC TGT TAA CCA ACT CCA ATC-3Ј and the pCMV2-pFLAG-IKK(␤K/ ␣LH) template to generate IKK(␤K/␣LH) SS/EE. Finally, to construct IKK(␤K/␣LH) SS/AA, IKK␤ SS/AA was used as the template in PCR with oligonucleotide primer set used for generation of the KD of IKK␤ SS/EE. The KD of IKK␤ SS/AA and the oligonucleotide primer 5Ј-CAT AGG AAG CTT TCA TTC TGT TAA CCA ACT CCA ATC-3Ј were used in PCR with the template pCMV2-pFLAG-IKK(␤K/␣LH) to generate IKK(␤K/␣LH) SS/AA. All IKK hybrid constructs were cloned into HindIII and KpnI restriction site of pCMV2-FLAG or pCMV1-Myc and subjected to DNA sequence analysis.
Assays of IKK Kinase Activity-Histidine and influenza hemagglutinin-tagged wild-type and hybrid IKK␣ and IKK␤ proteins were each cloned into the baculovirus expression vector (pAcHLT), and baculoviruses were generated by cotransfection with Baculo Gold recombinant DNA and transfer vectors (PharMingen). The recombinant baculoviruses were used to infect Sf9 cells to express the different IKK proteins. The IKK proteins were purified using nickel-agarose chromatography, immunoprecipitated with the 12CA5 monoclonal antibody, and then assayed in in vitro kinase assays as described (31) .
To assay the epitope-tagged IKK proteins, COS cells were transfected with CMV expression vectors containing the IKK cDNAs. Extracts prepared from these COS cells were suspended in lysis buffer containing 40 mM Tris-HCl, pH 8.0, 500 mM NaCl, 0.1% Nonidet P-40, 6 mM EDTA, 6 mM EGTA, 5 mM ␤-glycerophosphate, 5 mM NaF, 1 mM NaVO 4 , pH 10.0, and protease inhibitor (Roche Molecular Biochemicals). The cellular lysates (250 g) were subjected to immunoprecipitation with 500 ng of the anti-FLAG monoclonal antibody M2 or 50 l of 12CA5 supernatant to isolate the epitope-tagged IKK proteins, and protein G-agarose (20 l) was then added. After washing of the immunoprecipitates, kinase assays were performed at 30°C for 30 min with buffer containing 50 mM Tris-HCl, pH 8.0, 100 mM NaCl, 10 mM MgCl 2 , 1 mM dithiothreitol, 10 M ATP, 5 mM ␤-glycerophosphate, 5 mM NaF, 1 mM NaVO 4 , pH 10.0, 5 Ci of [␥-32 P]ATP, 5 g of the GST -IB␣ (aa 1-54). The kinase reaction mixtures were resolved by SDS-polyacrylamide gel electrophoresis, and phosphorylation of IB␣ was detected by autoradiography.
Western Blot Analysis-Whole cell lysates or immunoprecipitates were resolved by SDS-polyacrylamide gel electrophoresis. After transfer to nitrocellulose membranes (Amersham Pharmacia Biotech), monoclonal antibodies directed against FLAG (M2), the influenza hemagglutinin (12CA5), or Myc were added followed by anti-mouse IgG antibody. Proteins were detected with chemiluminescence reagents as described (Amersham Pharmacia Biotech).
RESULTS
Structure of IKK␣ and IKK␤-IKK is comprised of two catalytic subunits, IKK␣ and IKK␤, which have 52% amino acid identity (11) (12) (13) (14) (15) . In addition to an amino-terminal kinase domain, these proteins also have leucine zipper and helix-loophelix motifs. IKK␣ and IKK␤ kinase domains are present within their amino-terminal 300 amino acid residues, their leucine zipper domains are present between residues 455 and 485, and their HLH domains are present between residues 605 and 645 (11) (12) (13) (14) (15) . To characterize functional differences in these two kinases, chimeric kinases were constructed comprised of different domains of IKK␣ and IKK␤. The portions of IKK␣ in these fusions included the KD (aa 1-300), LZ (aa 301-554), and HLH (aa 555-745), whereas the regions of IKK␤ in these fusions included the KD (aa 1-300), LZ (aa 302-555), and HLH (aa 560 -756). A schematic of the IKK hybrids that were constructed is shown in Fig. 1 .
IKK (␣K/␤LH) and IKK (␤K/␣LH) in which the kinase domains of IKK␣ and IKK␤ were fused to the leucine zipper and helix-loop-helix domains of IKK␤ and IKK␣, respectively, were constructed. Two other hybrids, IKK (␣KL/␤H) and IKK (␤KL/ ␣H), in which the IKK␣ or IKK␤ kinase and leucine zipper domains were fused to the IKK␤ and IKK␣ helix-loop-helix domains, respectively, were also constructed. Finally we assayed mutants in which the serine residues in the activation loop of either IKK␣ or IKK␤ were changed to either alanine or glutamic acid (12, 25, 32) . These mutations were also inserted into IKK hybrids in which the IKK␣ kinase domain was fused to the IKK␤ leucine zipper and helix-loop-helix domain or the IKK␤ kinase domain was fused to the IKK␣ leucine zipper and helix-loop-helix domain. The kinase activity of each of the IKK hybrids was assayed alone or in the presence of NIK or MEKK1 expression plasmids (22, 28 -31, 33, 34 ). In addition, their kinase activity was assayed following baculovirus expression.
Domains in IKK␣ and IKK␤ That Regulate Their Kinase
Activity-Expression vectors containing the FLAG-tagged IKK␣ and IKK␤ constructs were transfected into COS cells either alone or in the presence of NIK or MEKK1. COS cell extracts were immunoprecipitated with the M2 monoclonal antibody directed against FLAG, and these kinases were assayed for their ability to phosphorylate GST-IB␣ (aa 1-54). First we assayed the IKK hybrids when low amounts of expression vector (0.1 g) were transfected into COS cells. In the absence of upstream kinases, wild-type IKK␤ had a 16-fold higher level of kinase activity than did wild-type IKK␣ (Fig. 2,  lanes 1 and 6) . None of the IKK hybrids resulted in detectable kinase activity when these low amounts of DNA were transfected into COS cells in the absence of NIK or MEKK1 (Fig. 2,  lanes 2-5) .
First we assayed the kinase activity of the IKK constructs when cotransfected into COS cells with MEKK1. MEKK1 activated wild-type IKK␣ kinase activity 50-fold and wild-type IKK␤ kinase activity 18-fold (Fig. 2, lanes 7 and 12) . MEKK1 also strongly stimulated the kinase activity of the IKK fusions IKK(␣K/␤HL) and IKK(␣KL/␤H) in which the IKK␣ KD was fused to the IKK␤ LZ and HLH domains or the IKK␣ KD and LZ domain were fused to the IKK␤ HLH domain, respectively (Fig. 2, lanes 8 and 10) . In contrast, there was little activation of kinase activity in the constructs IKK(␤K/␣LH) and IKK (␤KL/␣H) in which the IKK␤ KD was fused to the IKK␣ LZ and HLH domains or the IKK␤ KD and LZ domains were fused to the IKK␣ HLH domain respectively (Fig. 2, lanes 9 and 12) . There was no phosphorylation of a GST-IB␣ (aa 1-54) substrate mutant at serine residues 32 and 36 by either the wildtype or hybrid kinases (data not shown). These results indicate that the IKK␣ HLH domain when present in fusions containing the IKK␤ kinase domain does not result in efficient MEKK1 activation.
Cotransfection of NIK also resulted in increased kinase activity of each of the IKK constructs. Wild-type IKK␣ kinase activity was stimulated 50-fold, whereas wild-type IKK␤ kinase activity was stimulated 15-fold (Fig. 2, lanes 13 and 18) . The IKK hybrid IKK(␣K/␤LH), in which the IKK␣ KD was fused to the IKK␤ LZ and HLH domains, was activated 10-fold by NIK (Fig. 2, lane 14) . Similar levels of activation were seen with the other IKK hybrids except for the construct IKK(␤KL/ ␣H) in which the IKK␤ KD and LZ domains were fused to the IKK␣ HLH domain. The kinase activity of this construct was activated only 4-fold by NIK (Fig. 2, lane 17) . Hybrids containing the IKK␣ KD and the IKK␤ HLH domain (Fig. 2, lanes 14  and 16) had higher kinase activity than did hybrids containing the IKK␤ KD and the IKK␣ HLH domain (Fig. 2, lanes 15 and  17) . Western blot analysis indicated roughly equivalent expression of the IKK hybrids in addition to NIK and MEKK1 (Fig. 2,  middle and bottom panels) . These results, which were reproducible in four independent experiments, suggested that the IKK␣ HLH domain may play a potential negative role in activation by both NIK and MEKK1.
Kinase Activity of IKK␣ and IKK␤ Hybrids in the Absence of Upstream Kinases-The results presented in the previous section indicate that IKK␣ and IKK␤ hybrids can be activated by NIK and MEKK1, although IKK kinase activity was reduced in fusions containing the IKK␤ KD and the IKK␣ HLH domain. Next we compared the activity of the different IKK hybrids in the absence of cotransfection of MEKK1 and NIK. These proteins were expressed either by transfection of expression vectors into COS cells or following baculovirus expression and purification.
In contrast to the undetectable kinase activity seen when low quantities of IKK expression vectors were transfected in the absence of upstream kinases (Fig. 2) , transfection of larger The 756-amino acid IKK␤ protein is divided into the KD (aa 1-300), LZ (aa 302-559), and HLH (aa 560 -756) domains. IKK␣/IKK␤ hybrids were constructed by recombinant PCR using oligonucleotide primers that bind to the junctions of the different IKK␣ and IKK␤ domains. FLAG, influenza hemagglutinin, or Myc epitopes were inserted into the amino terminus of each of the IKK constructs. Recombinant PCR was also utilized to insert either glutamic acid or alanine residues for serine residues in the activation loop of several of these IKK proteins as indicated. These constructs were inserted downstream of the CMV promoter or into baculovirus expression vectors.
quantities of these expression vectors allowed us to detect IKK kinase activity in the absence of upstream kinases (Fig. 3) . Wild-type IKK␤ exhibited more than a 100-fold increase in in vitro kinase activity as compared with wild-type IKK␣ (Fig. 3A,  lanes 1 and 6) . IKK(␣K/␤LH), in which the IKK␣ KD was fused to the IKK␤ LZ and HLH domains, exhibited a 6-fold increase in kinase activity as compared with IKK␣ alone (Fig. 3A, lane  2) . A similar increase in kinase activity was seen with the fusion IKK(␣KL/␤H) in which the IKK␣ KD and LZ domains were fused to the IKK␤ HLH domain (Fig. 3A, lane 4) . However, the fusions IKK(␤K/␣LH) and IKK(␤KL/␣H), which contain the IKK␤ KD and the IKK␣ HLH domain, resulted in very low levels of kinase activity (Fig. 3A, lanes 3 and 5) . These results indicate that the IKK␤ HLH domain stimulates the activity of IKK hybrids containing the IKK␣ KD, whereas the IKK␣ HLH domain inhibits the activity of hybrids containing the IKK␤ KD.
Next, IKK proteins produced following baculovirus expression and purification were utilized to analyze the role of the HLH domains on regulating IKK activity. Wild-type IKK␤ had a 20-fold higher level of kinase activity than did wild-type IKK␣ (Fig. 3B, lanes 1 and 2) . The IKK hybrid IKK(␣K/␤LH), which contains the IKK␣ KD fused to the IKK␤ LZ and HLH domains, had a 3-fold higher kinase activity than did wild-type IKK␣ (Fig. 3B, lanes 1 and 3) . In contrast, the IKK hybrid IKK(␤K/␣LH), which contains the IKK␤ kinase domain fused to the IKK␣ LZ and HLH domains, had a 30-fold lower kinase activity than did wild-type IKK␤ (Fig. 3B, lanes 4 and 9) . These changes in kinase activity were due primarily to differences in the IKK␣ and IKK␤ HLH domains because fusion of these domains to either the IKK␤ KD and LZ or the IKK␣ KD and LZ, respectively, resulted in marked changes in IKK kinase activity (Fig. 3B, lanes 5 and 6) .
We also characterized the effects of mutation of serine residues in the IKK activation loop on the kinase activity of these baculovirus produced proteins. Substitution of alanine residues for serine residues in the activation loop markedly reduced IKK␣ and IKK␤ kinase activity (Fig. 3B, lanes 8 and 9) . In contrast, glutamic acid substitution for the serine residues in the activation loop slightly stimulated IKK␣ and IKK␤ kinase activity (Fig. 3B, lanes 9 and 10) . In summary, these results indicate a critical role for the IKK HLH domain on regulating IKK kinase activity.
Homodimer and Heterodimer Formation by IKK Hybrids-
The IKK␣ and IKK␤ leucine zipper domains are critical for the dimerization properties of these proteins. Biochemical analysis indicates that IKK␣/IKK␤ heterodimers are the predominant form of these kinases that are found in the 700-kDa IKK complex (11) (12) (13) (14) (15) . IKK␤ homodimers are found in a lower molecular IKK complex (25, 27) . The ability of these kinases to dimerize is critical for maintaining their kinase activity (11) (12) (13) (14) (15) . Thus it was important to address whether IKK hybrids were defective in their ability to either homodimerize or heterodimerize.
To assay the ability of the IKK hybrids to form homodimers, cotransfection of both FLAG-tagged and Myc-tagged IKK constructs was performed. Whole cell extracts were prepared from these transfected COS cells, and immunoprecipitation was performed with anti-FLAG antibody followed by Western blot analysis with anti-Myc antibody (Fig. 4A) . The epitope-tagged IKK hybrids formed roughly equivalent levels of homodimers (Fig. 4A, top panel) . Western blot analysis confirmed roughly equivalent expression of the epitope-tagged IKK proteins (Fig.  4A, middle and bottom panels) . 1-6) or in the presence of CMV expression vectors (1 g) containing either MEKK1 (lanes 7-12) or NIK or (lanes 13-18) . Whole cell lysates were prepared and immunoprecipitated with the anti-FLAG M2 monoclonal antibody and assayed for kinase activity in the presence of GST-IB␣ (aa 1-54) (top panel). Following SDS-PAGE, autoradiography was performed and gels were analyzed by PhosphorImager quantitation. Western blot analysis of the COS cell lysates was performed to detect expression from the IKK hybrids (M2/FLAG antibody) (middle panel) or NIK and MEKK1 (12CA5/Flu antibody) (bottom panel). WT, wild type.
FIG. 3. Differential effects of the IKK␣ and IKK␤ helix-loophelix domains on IKK kinase activity.
A, expression vectors encoding different IKK hybrids (1 g) were transfected into COS cells, and the cellular extracts were immunoprecipitated with the M2 monoclonal antibody. Kinase assays were performed with the GST-IB␣ (aa 1-54) substrate as described in Fig. 2 followed by SDS-PAGE and autoradiography (top panel) and PhosphorImager quantitation. The expression of the IKK hybrids was analyzed by Western blot analysis using the FLAG M2 monoclonal antibody (bottom panel). B, purified baculovirus expressed IKK proteins were analyzed in kinase assays with the GST-IB␣ (aa 1-54) substrate followed by SDS-PAGE and autoradiography and PhosphorImager quantitation (top panel). Western blot analysis of these IKK proteins was performed with the anti-FLAG M2 monoclonal antibody (bottom panel). WT, wild type.
Next we assayed the ability of each of these IKK hybrids to form heterodimers with either wild-type IKK␣ or IKK␤, respectively (Fig. 4B) . To assay heterodimer formation, each FLAGtagged IKK hybrid was cotransfected into COS cells with either wild-type Myc-tagged IKK␣ or IKK␤ constructs. The IKK hybrids were immunoprecipitated with anti-FLAG antibody, and Western blot analysis was performed with antibody directed against the Myc epitope. The IKK hybrid proteins each formed heterodimers with wild-type IKK␣ or IKK␤ (Fig. 4B, top panel) . Western blot analysis demonstrated roughly equivalent expression of each of the IKK hybrid proteins (Fig. 4B, middle  and bottom panels) . These results indicate that marked differences in the dimerization of the IKK hybrids was not responsible for alterations in their kinase activity.
Effect of Activation Loop Mutations on IKK Hybrid
Kinase Activity-The reduced kinase activity seen with the IKK hybrids containing the IKK␣ HLH domain could potentially result from reduced phosphorylation of serine residues in their activation loop by upstream kinases. To address this possibility, we assayed the effects of conversion of serine residues in the activation loop of IKK to glutamic acid (12, 25) . Thus we could evaluate whether glutamic acid substitution, which mimics serine phosphorylation, could restore the kinase activity of IKK hybrids that exhibited reduced phosphorylation of IB␣. In addition, we assayed the effect of mutations of serine residues in the activation loop of IKK to alanine residues to prevent serine phosphorylation (12, 32, 34) . Expression vectors containing wild-type or mutant IKK␣, IKK␤, IKK(␣K/␤LH), or IKK(␤K/␣LH) were transfected into COS cells followed by immunoprecipitation of these FLAG-tagged IKK proteins and assays of their kinase activity. The quantity of IKK expression vectors transfected in this experiment resulted in efficient in vitro kinase activity in the absence of NIK or MEKK1.
As demonstrated previously, wild-type IKK␤ had a 50-fold higher level of kinase activity for IB␣ as compared with IKK␣ (Fig. 5, lanes 1 and 9) . Glutamic acid substitution of serine residues in the activation loop of IKK␣ (SS/EE) and IKK␤ (SS/EE) resulted in only about a 2-fold increase in kinase activity as compared with that seen with the wild-type IKK proteins (Fig. 5, lanes 1, 2, 11, and 12) . In contrast, substitution of alanine residues for serine residues in the IKK activation loop reduced IKK␣ and IKK␤ kinase activity more than 10-fold (Fig. 5, lanes 3 and 6) . The kinase activity of the IKK(␤K/␣LH) SS/EE protein was reduced more than 15-fold as compared with the IKK(␣K/␤LH) SS/EE protein (Fig. 5, lanes 4 and 7) . There was no detectable kinase activity in the IKK hybrids containing the SS/AA mutation in which the serine residues were changed to alanine (Fig. 5, lanes 5 and 8) . Western blot analysis indicated no significant differences in the expression of these IKK proteins (Fig. 5, lower panel) . These results suggest that the difference in the IKK␣ and IKK␤ HLH domains, rather than reduced phosphorylation in their activation loops, is likely the critical determinant in the differential kinase activity of the IKK hybrids.
Effect of Aspirin and Sulindac Sulfide on Inhibiting the Kinase Activity of IKK Hybrids-Aspirin and sodium salicylate, unlike several other anti-inflammatory agents including indomethacin that also inhibit prostaglandin synthesis, reduces activation of the NF-B pathway (31, 42, 43) . Aspirin prevents IB degradation and the nuclear translocation of NF-B by binding to IKK␤ to decrease its kinase activity. Sulindac, an anti-inflammatory agent that is structurally related to indo- methacin, also inhibits prostaglandin synthesis (44 -47) . Sulindac is metabolized into two forms that include a sulfide and sulfone. The sulfide is the major active metabolite of sulindac and potently inhibits prostaglandin synthesis (45) . Sulindac and its metabolites, especially sulindac sulfide, can also inhibit activation of the NF-B pathway by decreasing IKK kinase activity (40) .
We utilized IKK hybrids to characterize domains in IKK that are targets for aspirin and sulindac sulfide inhibition of the NF-B pathway. COS cells were transfected with expression vectors encoding the FLAG-tagged IKK hybrids alone (Fig. 6A ) or in the presence of NIK (Fig. 6B) . At 30 h post-transfection, the COS cells were treated with buffer alone, aspirin, or sulindac sulfide for 2 h prior to harvesting. Following immunoprecipitation with the M2 monoclonal antibody, the kinase activity of the IKK proteins was assayed. With the quantities of IKK expression vectors transfected, there was little kinase activity seen in the absence of NIK (Fig. 6A) . In contrast, the kinase activity of wild-type IKK␣ and IKK␤ and the hybrids IKK(␣K/ ␤LH) and IKK(␤K/␣LH) were strongly induced by cotransfection with NIK. There was little detectable kinase activity seen with the IKK(␣KL/␤H) and IKK(␤KL/␣H) constructs at the concentrations of these expression vectors used in transfection (Fig. 6B) .
Differential inhibition of these IKK hybrids with aspirin treatment was noted. The kinase activity of IKK␣ was not significantly inhibited by aspirin treatment (Fig. 6B, lanes  1-3) , whereas the kinase activity of IKK␤ was reduced 3-fold by aspirin treatment (Fig. 6B, lanes 16 -21) . Interestingly, the kinase activity of IKK(␣K/␤LH) was reduced 4-fold by aspirin treatment (Fig. 6B, lanes 4 and 5) , whereas the kinase activity of IKK(␤K/␣LH) was not inhibited by aspirin (Fig. 6B, lanes 7  and 8) . These results indicate that the presence of the IKK␤ LZ and HLH domains, but not corresponding domains in IKK␣, are associated with aspirin inhibition of IKK kinase activity.
In contrast to the results with aspirin, sulindac sulfide resulted in 35-fold inhibition of wild-type IKK␣ kinase activity and more than 100-fold inhibition of IKK␤ kinase activity (Fig.  6B, lanes 3, 18, and 21 ). In addition, the kinase activity of the IKK hybrids, IKK(␣K/␤LH) and IKK(␤K/␣LH), was inhibited by more than 100-fold by the addition of sulindac sulfide (Fig.  6B, lanes 6 and 9) . Western blot analysis indicated similar expression of these IKK proteins (Fig. 6B, lower panel) . Neither aspirin nor sulindac sulfide treatment markedly inhibited the in vitro kinase activity of an epitope-tagged ERK2 protein that was expressed following transfection and phorbol ester treatment of COS cells (Fig. 6B, lanes 22-24) . Thus sulindac sulfide inhibition of IKK kinase activity is potentially mediated via interactions with the IKK␣ and IKK␤ kinase domains. These results indicate that different domains in IKK are likely responsible for aspirin and sulindac sulfide inhibition of IKK kinase activity.
DISCUSSION
The IB kinases, IKK␣ and IKK␤, are critical in activating the NF-B pathway (11) (12) (13) (14) (15) . Although both of these kinases phosphorylate IB␣, they differ markedly in their kinase activity for this substrate. For example, IKK␤ phosphorylates amino-terminal serine residues in IB with a 10 -20 fold higher level of activity than does IKK␣ (12, 14, 29 -31) . Gene disruption studies in mice indicate that IKK␤ is much more critical in activation of the NF-B pathway by tumor necrosis factor ␣ and interleukin-1 than is IKK␣ (36 -39) . To further characterize the function of these kinases, hybrids containing different domains of these kinases were constructed, and their kinase activity was assayed.
The analysis of hybrid IKK kinases indicates that their activity varies depending on which domains in IKK␣ and IKK␤ are present. First, under all assay conditions IKK␤ has a significant higher level of kinase activity as compared with IKK␣. Although IKK␣ and IKK␤ have a high degree of homology, we were unable to completely restore IKK␤ kinase activity by 1-21) or ERK2 in the presence of TPA (50 ng/ml) for 30 min prior to harvesting. Buffer alone (PBS), aspirin (ASA) (5 mM), or sulindac sulfide (SS) (200 M) was added to COS cells for 2 h prior to harvesting. Kinase assays were performed following immunoprecipitation with the M2 monoclonal antibody using GST-IB␣ (aa 1-54) as the substrate (lanes 1-21) The roles of the IKK␣ and IKK␤ KD and LZ domains in regulating kinase activity were also assayed. Homodimerization and heterodimerization of these hybrid kinases occur when either the IKK␣ and IKK␤ LZ domains were transferred to the corresponding kinase. Although there are likely intrinsic differences in the ability of the IKK␣ and IKK␤ kinase domains to phosphorylate IB, a critical feature modulating their activity was the HLH domain. These results are consistent with previous data, which suggest that the HLH domain is critical in regulating IKK activity (32, 35) .
Another element that is critical in regulating IKK function is phosphorylation of serine residues in their activation loop (11) (12) (13) (14) (15) . Upstream kinases including NIK and MEKK1 are able to phosphorylate these residues to increase IKK kinase activity (22, 28, 29, (32) (33) (34) . Mutation of these serine residues to alanine markedly reduces IKK␤ (12, 32) and IKK␣ kinase activity (12, 34) . Conversion of serine residues in the IKK activation loop to glutamic acid has been demonstrated to mimic serine phosphorylation and result in at least 10-fold increases in kinase activity as compared with wild-type IKK (12, 25) . These constitutively active IKK proteins were expressed as individual subunits in either reticulocyte lysate and or following baculovirus expression. In our study, we find that these constitutively active IKK constructs produced following transfection of COS cells result in only slightly increased kinase activity as compared with that seen with wild-type IKK. These results suggest that either the formation of IKK heterodimers in vivo may down-regulate the kinase activity of constitutively active IKK or that negative factors may associate with this kinase to down-regulate its activity. Finally, data indicate that carboxylterminal phosphorylation of IKK can markedly influence IKK␤ kinase activity (32) . These results implicate multiple mechanisms in modulating IKK activity.
The question arises why IKK␣ and IKK␤ are present in a heterodimer form when IKK␤ appears to be the critical IKK kinase. The reasons for this remain speculative. It is possible that IKK␣ may serve to facilitate the association of the IKK complex with additional proteins in the large multiprotein IKK complex. Such effects could facilitate the association of the IKK complex with upstream kinases that stimulate IKK activity. It is also possible that the association of IKK␣ with IKK␤ may serve to downregulate IKK␤ kinase activity. This could result in lower activity of the IKK␣/IKK␤ complex as compared with the IKK␤ homodimer. Finally, IKK␣ could potentially regulate IKK␤ kinase activity by serving as an upstream kinase that can phosphorylate IKK␤ to increase its activity. Further studies will be necessary to address the role of IKK␣ in regulating the NF-B pathway.
Additional cellular factors not analyzed in this study also regulate IKK␣ and IKK␤ kinase activity. For example, IKK␥ or NEMO via its coiled-coil domain dimerizes efficiently with IKK␤ but not IKK␣ (23) (24) (25) . NEMO increases IKK␤ kinase activity and modulates the response of IKK␤ to upstream activators such as tumor necrosis factor ␣ and interleukin-1. NEMO is able to interact with IKK(␤KL/␣H), which has little kinase activity. 2 In addition, baculovirus expressed IKK proteins exhibit marked dependence on the IKK HLH domains in the absence of NEMO. Thus, although NEMO is critical for IKK␤ function in vivo, defects in NEMO binding to IKK do not appear to be sufficient to explain the role of the HLH domain on IKK activity.
The hybrid IKK proteins analyzed in this study have allowed us to more carefully study the function of the domains in IKK␣ and IKK␤ that regulate their kinase activity. In addition, these constructs may prove useful in identifying differences in the mechanism of action of inhibitors of IKK activity. Although aspirin appears to target the IKK␤ HLH domain for its inhibitory effects on IKK kinase activity (31), sulindac sulfide inhibition is likely mediated by effects on the kinase domains of both IKK␣ and IKK␤. This analysis suggests that different IKK domains may be targets for the inhibitors of IKK activity. Further studies will be required to better understand the IKK structural features involved in their regulation of the NF-B pathway.
